Gut Microbiota Market Players:
- Merck KGaA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Metabiomics Corporation
- ViThera Pharmaceuticals, Inc.
- Second Genome Inc.
- Microbiome Therapeutics LLC
- Vedanta Biosciences, Inc.
- Osel, Inc.
- Synthetic Biologics, Inc.
- Synlogic
- 4D Pharma plc
- Metabogen AB
- Symbiotix Biotherapies, Inc.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2026, the industry size of gut microbiota is evaluated at USD 1 billion.
The global gut microbiota market size exceeded USD 860.4 million in 2025 and is set to expand at a CAGR of over 18.4%, surpassing USD 4.66 billion revenue by 2035.
North America gut microbiota market will hold around 35% share by 2035, driven by rising concern about digestive illnesses and increasing healthcare spending.
Key players in the market include Merck KGaA, Metabiomics Corporation, ViThera Pharmaceuticals, Inc., Second Genome Inc., Microbiome Therapeutics LLC, Vedanta Biosciences, Inc., Osel, Inc., Synthetic Biologics, Inc., Synlogic, 4D Pharma plc, Metabogen AB, Symbiotix Biotherapies, Inc.
